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a  b  s  t  r  a  c  t
A group  of 8 dogs  was  treated  with  an  imidacloprid/ﬂumethrin  collar  (Seresto®)  28  days
prior  to infestation  with  adult  Dermacentor  reticulatus  ticks,  infected  with  Babesia canis.
The ability  of  the  collar  to prevent  transmission  of  B.  canis  in  the  treated  group  was  com-
pared to an  untreated  control  group.  All 8 dogs  in  the untreated  control  group  became
infected with  B.  canis  parasites,  which  were  detected  in  blood  smears  as early  as  day  6  post
tick-application.  All  control  dogs  developed  clinical  signs  of  babesiosis  and  were  rescue-
treated with  imidocarb  dipropionate.  These  dogs  also  developed  speciﬁc  B. canis  antibodies
as identiﬁed  by  serology  (IFA  test)  and  were  conﬁrmed  PCR/RLB  positive.
None  of the  8 dogs  treated  with  the  imidacloprid/ﬂumethrin  collar  became  infected  with
B. canis,  which  was  conﬁrmed  by the  absence  of speciﬁc  B.  canis  antibodies  and  babesial
DNA  as conﬁrmed  by  PCR/RLB.ransmission blocking The collar  caused  96.02%  of  the  ticks  to die  within  48  h  post  challenge  and  this  increased
to  100%  within  4 days.  Although  a high  percentage  of 44%  of the  Dermacentor  ticks  were
infected  with  B. canis,  they were  unable  to  transmit  the  infection  to  the  treated  group.
Hence,  the  imidacloprid/ﬂumethrin  collar  effectively  prevented  transmission  of B. canis  1
ation  o
 month after  applic
. Introduction
Worldwide, dogs are exposed to a broad range of proto-
oan and bacterial pathogens transmitted by infected ticks.
anine  babesiosis, monocytic ehrlichiosis and granulocytic
naplasmosis are the pre-dominant tick-borne diseases of
ogs  (Jongejan and Uilenberg, 2004). Ticks and tick-borne
iseases that affect dogs in different regions of the world
re  expanding (Chomel, 2011). Since international travel
ith  companion animals is now quite common, ticks and
ssociated diseases are also crossing borders and are caus-
ng  novel emerging disease threats (Beugnet and Marié,
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2009). Moreover, over the past two decades several novel
tick-borne infections have been identiﬁed, whereas oth-
ers  are regarded as re-emerging diseases of dogs (Chomel,
2011).
The  vectorial capacity of ticks infesting dogs varies
widely. For instance, the cosmopolitan tick, Rhipicephalus
sanguineus, transmits Babesia vogeli, Babesia gibsoni, Hep-
atozoon  canis, Ehrlichia canis and Rickettsia conorii, and
probably also Anaplasma platys, the cause of throm-
bocyic anaplasmosis. Ixodes ricinus ticks are widely
distributed throughout Europe, where they transmit Bor-
relia  burgdorferi and Anaplasma phagocytophilum, both
zoonotic pathogens, which are affecting a broad range of
Open access under CC BY-NC-ND license.hosts,  including dogs.
In  this paper we have studied the ornate dog tick, Der-
macentor reticulatus, which is a vector of a broad spectrum
of  pathogens, including B. canis in dogs, Babesia caballi
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in horses, Anaplasma marginale in cattle and a number
of zoonotic rickettsial species. D. reticulatus is expanding
its distributional range within Europe into, for instance,
Hungary, The Netherlands, Norway and elsewhere (Sréter
et al., 2005; Matjila et al., 2005; Øines et al., 2010). This has
led to cases of canine babesiosis being detected in regions
where the disease had previously not been encountered,
which adds to the relevance of practicing acaricidal tick
control on dogs.
Therefore, acaridical treatment that kills ticks and thus
reduces the effective tick population capable of transmiting
disease-inducing pathogens, seems evident. Importantly, it
would be a signiﬁcant step forward, if it could be demon-
strated that the rapid killing of infected ticks on dogs could
actually prevent tick-borne disease to develop at all.
Acaricidal control of ticks on dogs is a nessessity in many
parts of the world. The active compounds are predomi-
nantly applied as shampoos, powders, spot-ons, sprays and
impregnated collars. Acaricide impregnated collars have
been widely used against ticks on companion animals (Van
den Bos and Curtis, 2002; Fourie et al., 2003; Estrada-
Pena and Reme, 2005). For instance, ﬂumethrin, a synthetic
pyrethroid, has been extensively used in livestock as an
acaricide over the past 25 years and has also been used
in a collar preparation in combination with propoxur to
control ticks on dogs (Fourie et al., 2003). Furthermore,
imidacloprid is a highly effective insecticide, registered for
use in dogs and cats as a spot-on product and is also avail-
able in combination with permethrin (another pyrethroid)
for spot-on use in dogs (Advantix ®) (Hellmann et al.,
2003).
Recently, a combination of imidacloprid (10%) with
ﬂumethrin (4.5%) has been formulated in a collar matrix
which proved safe to dogs and cats. Moreover, this col-
lar exhibited a sustained high level of efﬁcacy against ticks
(Stanneck et al., 2012). Consequently, this collar may  have
the potential to prevent the transmission of vector-borne
diseases.
This study was designed with the aim to evaluate the
efﬁcacy of an imidacloprid/ﬂumethrin collar formulation in
preventing the transmission of B. canis to dogs by infected
D. reticulatus ticks.
2. Materials and methods
The study was conducted according to International
Cooperation on Harmonization of Technical Requirements
for Registration of Veterinary Medicinal Products Guide-
line 9: Good Clinical Practice (Anonymous, 2000). The study
was a parallel group design, randomised, unicentre, con-
trolled efﬁcacy study using two groups of eight dogs each.
Group 1: negative control (n = 8); Group 2: dogs ﬁtted with
the collar on day −28 (n = 8). The negative control group
was not treated with a placebo collar making blinding of
the study impossible. On day −30 the 16 dogs were ranked
according to body weight, within gender (9 male and 7
female), in descending order from 16.6 to 10.8 kg indi-
vidual body weight. Animal ID’s were used to break ties.
Within each gender animals were then blocked into blocks
of two dogs each. Within each block, dogs were randomly
allocated to Groups 1 or 2. The dogs were sub adult andology 192 (2013) 273– 278
adult dogs of mixed breed mainly mongrel. All dogs were
dewormed and did not harbour any ticks at the initiation
of the study. The dogs had not been treated with an aca-
ricide/insecticide spot-on/spray for 12 weeks prior to tick
infestation (day 0). All were serologically negative for B.
canis prior to day −35. The study animals were acclimatised
for 7 days prior to the treatment. The study animals were
kept individually in pens in compliance with local animal
welfare regulation.
All the animals were observed daily for general health
conditions and clinical signs of adverse reactions to treat-
ment. All dogs were subjected to a clinical examination
on days −35, +7, +14, +21 and +27. Additionally clinical
examinations were conducted on all dogs displaying clini-
cal signs (elevated body temperature, anaemia, haematuria
and/or icterus) associated with babesiosis. The dogs were
observed on an approximately hourly basis for 4 h after
ﬁtting the collar for possible adverse events. Rectal body
temperatures were recorded daily from days +6 to +13.
Clinical examinations were conducted and two blood
smears were prepared for dogs displaying abnormally high
body temperatures (>39.4 ◦C).
Blood for PCR was collected from all dogs diagnosed
with babesiosis as conﬁrmed on a blood smear and from
all dogs not yet diagnosed with babesiosis on days +14,
+21 and +28. Blood was  collected in EDTA tubes and stored
at −30 ◦C prior to DNA extraction. PCR ampliﬁcation and
reverse line blot hybridisation (RLB) was carried out as
described by Matjila et al. (2005), employing an improved
laboratory protocol for detecting and differentiation of
canine Babesia species. The protocol was  improved by the
addition of an internal quality plasmid control to check
whether all probes were functioning properly. PCR-RLB
tests were only conducted on blood samples collected from
dogs that were diagnosed with B. canis infection based on
blood smears or IFA test.
Blood for serology (IFA test) was collected on day +14,
+21 and +28 and frozen at −20 ◦C until assayed for B. canis
antibodies. An indirect ﬂuorescent antibody (IFA) test was
used with B. canis antigen as substrate (Uilenberg et al.,
1989). All sera were diluted at 1:80. Sera were recorded as
positive if speciﬁc ﬂuorescence was observed at dilution
1:80 or negative (no ﬂuorescence).
A laboratory-bred D. reticulatus tick strain infected with
Babesia canis-was used in the artiﬁcial infestations. A sam-
ple of D. reticulatus ticks was taken from the batch of ticks to
be used for infestation and the infection rate determined.
16 out of 36 ticks (44%) were found to be infected with
Babesia canis by PCR-RLB analysis. RLB analysis also con-
ﬁrmed that the ticks were not infected with any other
known tick-borne pathogen. Adult ticks, which were used
in the artiﬁcial infestations, were unfed, at least 1 month
old and had a balanced sex ratio (50% female: 50% male).
Each dog was artiﬁcially infested with approximately 50
ticks on day 0. The time of infestation was  recorded for all
animals.
The time of tick counting was recorded. Day +2, +3,
+4 and +5 tick counts were conducted in situ. During the
in situ thumb counts, ticks were categorised according to
categories 1, 2, 4 and 5. The ticks counted and removed
on day +6 were categorised within gender (male/female)
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Table  1
Categorization of ticks for counting.
Category General ﬁndings Attachment status
1 Live Free
2 Live Attached; unengorgeda
3 Live Attached; engorgedb
4 Killed Free
5 Killed Attached; unengorgeda
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06 Killed Attached; engorged
a No ﬁlling of the alloscutum evident.
b Obvious or conspicuous ﬁlling of the alloscutum evident.
ccording to categories 1–6 (see Table 1), adapted after
archiondo et al. (2007).
SAS Version 8 (release 8.02 TS Level 02M0) was used
or all the statistical analyses. Efﬁcacy against ticks was
alculated for each treatment group at each assessment
ay according to the formulas given below (EMEA, 2007).
ue to the fact that small and even zero tick counts were
ecorded, it was  expected that the tick counts would not
ollow a normal distribution. It was therefore decided
hat the primary efﬁcacy calculations would be based on
eometric means rather than arithmetic means. The cal-
ulations were based on the geometric means of the tick
count + 1) data. One (1) was subsequently subtracted from
he result to obtain a meaningful value for the geomet-
ic mean of each treatment group. Percent efﬁcacy against
icks was calculated as follows:
fﬁcacy (%) = 100 × Gmc − Gmt
Gmc
,
here Gmc is the geometric number of live ticks (categories
–3) on dogs in the negative control group (Group 1) at a
peciﬁc time point. Gmt is the geometric mean number of
ive ticks and dead ticks (categories 1–3 and 6; (see Table 1)
esidual efﬁcacies) in the treatment group (Group 2) at a
peciﬁc time point (EMEA, 2007).
Descriptive statistics (mean, minimum, maximum,
tandard deviation, CV%, geometric mean and median) on
ick counts for the various assessment days were calcu-
ated.
The groups were compared using an ANOVA with a
reatment effect after a logarithmic transformation on the
ick (count + 1) data. The level of signiﬁcance of the formal
ests was set at 5%, all tests were two sided.
A protection failure (successfully infected) was regarded
hen a dog in the treatment group tested serologically pos-
tive for Babesia canis antibodies as well as positive for B.
anis DNA in PCR-RLB assay.
The percentage protection for the treatment group was
alculated as follows:
rotection (%) = 100 × Tc − Tt
Tc
,
here Tc is the total number of infected dogs in the negative
ontrol Group 1 and Tt is the total number of infected dogs
n the treatment Group 2.. Results
The tick counts for the two study groups are given
n Table 2. The geometric mean tick counts recorded for Ta
b
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Table 3
Mean tick counts by treatment group and percentage efﬁcacies.
Day Geometric mean tick counts
Group 1 – negative control Group 2 – dogs ﬁtted with collar
+2b 23.1 0.9a
+3b 21.8 0.2a
+4b 22.4 0.0a
+5b 20.3 0.0a
+6 18.7 0.0a
Day Efﬁcacies (%)
Group 2 – (dogs ﬁtted with collar)
+2b 96.02
+3b 99.1
+4b 100.0
+5b 100.0
+6 100.0
a Geometric mean tick count differs statistically signiﬁcantly (p < 0.05) from that recorded for the negative control Group 1.
b In situ counts.
Table 4
A summary of clinical observations recorded.
Dog number Group Day Fever Blood smear Other observations
3
1 +6
40.5 ◦C Positive for Babesia canis Not observed
7 39.8 ◦C Positive for B. canis Not observed
2
1
+7
39.9 ◦C B. canis + Haemoglobinuria
3  39.4 ◦C B canis + Haemoglobinuria
5  39.5 ◦C B. canis + Not observed
6 40.3 ◦C B. canis + Haemoglobinuria
8  39.7 ◦C B. canis + Not observed
7 40.5 ◦C B. canis + Haemoglobinuria
◦
 for B. c
sitive fo
for B. canis antibodies on any of the post challenge time
points (Table 5). PCR-RLB tests that were conducted on dogs
that were diagnosed with B. canis based on blood smear
Table 5
Babesia canis antibodies in individual dogs according to treatment group.
Dog number Group Day −35 Day 0 Day 14 Day 21 Day 28
1
1
– – POS POS POS
2 – – POS POS POS
3 – – POS POS POS
4 – – POS POS POS
5 – – POS POS POS
6 – – – POS –
7 – – – POS POS
8 – – POS POS POS
1
2
– – – – –
2 – – – – –
3 – – – – –
4 – – – – –
5 – – – – –1  2 38.7 C Negative
6E1  208 1 +9 No fever; blood smear po
both groups are summarised in Table 3. A mean tick count
of 23.1 was recorded for the untreated negative control
group on day +2 indicating a vigorous tick challenge. Efﬁ-
cacy values (%) based on geometric mean tick counts for
the treated group are also summarised in Table 3. The
collar was highly effective against challenges with D. retic-
ulatus ticks 1 month after application. Tick mortality as
high as 96.02% was recorded 48 h post challenge with
100% of all infested ticks being dead within 4 days post
challenge.
The clinical signs observed in the untreated control
group were correlated with onset and progress of babesio-
sis and are summarised in Table 4. On day 6 post tick
application, two dogs reacted with fever and Babesia para-
sites were detected in blood smears. The next day both dogs
displayed fever again and parasites were again detected.
Both were treated with imidocarb dipropionate (12%) and
recovered. Four other dogs developed fever on day 7
and were positive on blood smears (Table 4). The two
remaining dogs in the untreated group did not develop
fever, but were depressed with pale mucous membranes
and enlarged spleen upon palpation with blood smears
revealing the presence of Babesia parasites. All 8 dogs
were rescue treated with imidocarb dipropionate and fully
recovered.
All dogs included in the study tested negative for B.
canis antibodies in the IFA assay prior to tick infestation.anis Tremors – nervousness
r B. canis. Depressed; enlarged spleen; pale mucous membranes
Eight of 8 untreated control dogs developed speciﬁc anti-
bodies to B. canis on one or more post-challenge time
points (Table 5). None of the treated dogs tested positive6 – – – – –
7 – – – – –
8 – – – – –
POS: positive for Babesia canis antibodies; −, negative for Babesia canis
antibodies.
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Table  6
Detection of Babesia canis DNA by PCR/RLB in individual dogs.
Dog number Group Day 6 Day 7 Day 8 Day 9 Day 10 Day 11 Day 12 Day 13
1
1
– – – POS – – – –
2  – POS – – – – – –
3  POS – – – – – – –
4  – – – POS – – – –
5 – POS – – – – – –
6 – POS – – – – – –
7  POS – – – – – – –
8  – POS – – – – – –
1
2
–  – – – – – – –
2  – – – – – – – –
3  – – – – – – – –
4  – – – – – – – –
5  – – – – – – – –
6 – – – – – –  – –
7  – – – – – – – –
P
e
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C8 –  – – 
OS: conﬁrmed positive for Babesia canis DNA; −, tested negative.
valuation were all conﬁrmed B. canis positive at differ-
nt time points from day 6 to day 9 after tick challenge
Table 6).
The level of protection (100%) of the imidaclo-
rid/ﬂumethrin collar in preventing transmission of B. canis
y infected Dermacentor ticks is summarised in Table 7,
ogether with the 95% conﬁdence interval (69–100%) and
-value (0.0002) from the Fisher’s exact test.
. Discussion and conclusion
The imidacloprid/ﬂumethrin collar, which has recently
een registered (Seresto®) by Bayer Animal Health GmbH
Leverkusen, Germany) was well tolerated by the dogs.
he efﬁcacy of 96.02% of ticks killed 48 h post challenge,
hich increased to 100% mortality within 4 days, was in
ine with the reported efﬁcacy above 97% against adult D.
eticulatus ticks (Stanneck et al., 2012). Moreover, the speed
f kill by the collar against infesting ticks is of particular
mportance with respect to the ability to block transmis-
ion of pathogens. Evidently, this speed was sufﬁcient in
rder to prevent transmission of mature Babesia sporo-
oites into the treated dogs, whereas they were readily
ransmitted to the untreated control group. Development
f Babesia sporoblasts into mature sporozoites within the
ick’s salivary gland was therefore prevented by the treat-
ent, despite the fact that 44% of the ticks were infected.
oreover, it has been demonstrated that this collar has a
ustained acaricidal (48 h killing) efﬁcacy over a period of
able 7
omparison of treated and control dog group for Babesia canis infection.
Group 1
(n = 8)
Group 2
(n = 8)
Infected 8 0
Non-infected 0 8
%  Infected 100 0
%  Protection – 100
95% Conﬁdence interval: % protection 69–100
p-Value – 0.0002– – – – –
8 months (Stanneck et al., 2012). This proven sustainable
high efﬁcacy of the collar over 8 months strongly suggests
that the prevention of B. canis transmission may  have the
same duration.
Transmission blocking has become a novel standard in
the evaluation of the capacity of anti-tick compounds to
prevent transmission of tick-borne pathogens to dogs: The
transmission blocking model for D. reticulatus ticks as used
in the present study was recently developed and used suc-
cessfully for the ﬁrst time with a novel combination of
ﬁpronil, amitraz and (S)-methoprene (Certifect®) (Jongejan
et al., 2011). The advantage of this model is that the chal-
lenge load with infected ticks can be pre-determined and
standardised. Several other studies have been carried out
to ascertain the capability of various anti-tick compounds
to prevent transmission of tick-borne pathogens to dogs.
In these studies, dogs were either exposed to infected
ticks under ﬁeld conditions or infected ticks were collected
from the ﬁeld and tested on dogs under controlled lab-
oratory conditions (Spencer et al., 2003; Jacobson et al.,
2004; Blackburn et al., 2004; Last et al., 2007; McCall et al.,
2011).
For instance, the capacity of an amitraz-impregnated
collar to block transmission of Babesia rossi by Haema-
physalis elliptica ticks has been evaluated in the ﬁeld in
South Africa. Eight of 30 control dogs (26.6%) became
PCR/RLB positive during the trial period, which lasted
for 6 months. None of the treated dogs became infected
with babesiosis during the same period (Last et al., 2007).
Furthermore, in a laboratory study targetting B. burgdor-
feri, when challenge infestation was conducted 28 days
after application of ﬁpronil/(S)-methoprene, the treatment
prevented all but 2 of 16 dogs from becoming infected
and was 97.6% effective against tick infestation 48 h after
tick challenge (Jacobson et al., 2004). In addition, imi-
dacloprid/permethrin spot-on prevented transmission of
A. phagocytophilum from ﬁeld collected Ixodes scapularis
ticks reported by Blagburn et al. (2004).  Recently, the
ability of the topical combination of ﬁpronil, amitraz
and (S)-methoprene protected dogs from B. burgdorferi
and A. phagocytophilum using dual infected ﬁeld collected
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I. scapularis ticks (McCall et al., 2011). The question about
the speed of transmission and the early events after tick
attachment may  be easier to address by using in vitro tick
feeding methods (Kröber and Guerin, 2007).
As discussed above, blocking of transmission of vector
borne diseases is currently becoming a standard evaluation
of highly effective acaricides. As a consequence, guidelines
for evaluating efﬁcacy of ectoparasiticides for treatment,
prevention and control of tick infestations on dogs are
expected to be revised. This is important in order to accom-
modate the testing of their ability to block transmission
of tick-borne pathogens and prevent disease (Marchiondo
et al., 2007).
Finally, similar models have now been developed for
studying the transmission blocking capacity of other tick-
borne pathogens, in particular Babesia vogeli and Ehrlichia
canis, both transmitted by the cosmopolitan dog tick, Rhipi-
cephalus sanguineus.
In conclusion, the imidacloprid/ﬂumethrin collar was
highly effective against challenge with D. reticulatus ticks
1 month after application. The high acaricidal efﬁcacy
resulted in a 100% protection level (95% conﬁdence inter-
val: 69–100%) of the collar to prevent transmission of
Babesia canis by infected D. reticulatus ticks applied 1 month
after the dogs were treated with the collar.
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